A Novel Scoring System for Prediction of Disease Severity in COVID-19

被引:76
作者
Zhang, Chi [1 ]
Qin, Ling [1 ]
Li, Kang [1 ]
Wang, Qi [1 ]
Zhao, Yan [1 ]
Xu, Bin [1 ]
Liang, Lianchun [1 ]
Dai, Yanchao [1 ]
Feng, Yingmei [1 ]
Sun, Jianping [1 ]
Li, Xuemei [1 ]
Hu, Zhongjie [1 ]
Xiang, Haiping [1 ]
Dong, Tao [2 ,3 ]
Jin, Ronghua [1 ]
Zhang, Yonghong [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China
[2] Univ Oxford, Oxford Inst COI, Chinese Acad Med Sci, Oxford, England
[3] Univ Oxford, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2020年 / 10卷
基金
英国医学研究理事会; 北京市自然科学基金;
关键词
logistic regression; severity pneumonia; COVID-19; retrospective cohort; prediction scoring system; CORONAVIRUSES; REPLICATION;
D O I
10.3389/fcimb.2020.00318
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background:A novel enveloped RNA beta coronavirus, Corona Virus Disease 2019 (COVID-19) caused severe and even fetal pneumonia in China and other countries from December 2019. Early detection of severe patients with COVID-19 is of great significance to shorten the disease course and reduce mortality. Methods:We assembled a retrospective cohort of 80 patients (including 56 mild and 24 severe) with COVID-19 infection treated at Beijing You'an Hospital. We used univariable and multivariable logistic regression analyses to select the risk factors of severe and even fetal pneumonia and build scoring system for prediction, which was validated later on in a group of 22 COVID-19 patients. Results:Age, white blood cell count, neutrophil, glomerular filtration rate, and myoglobin were selected by multivariate analysis as candidates of scoring system for prediction of disease severity in COVID-19. The scoring system was applied to calculate the predictive value and found that the percentage of ICU admission (20%, 6/30) and ventilation (16.7%, 5/30) in patients with high risk was much higher than those (2%, 1/50; 2%, 1/50) in patients with low risk (p= 0.009;p= 0.026). The AUC of scoring system was 0.906, sensitivity of prediction is 70.8%, and the specificity is 89.3%. According to scoring system, the probability of patients in high risk group developing severe disease was 20.24 times than that in low risk group. Conclusions:The possibility of severity in COVID-19 infection predicted by scoring system could help patients to receiving different therapy strategies at a very early stage. Topic:COVID-19, severe and fetal pneumonia, logistic regression, scoring system, prediction.
引用
收藏
页数:7
相关论文
共 26 条
  • [1] Impact of weight reduction on selected immune system response among Hepatitis C virus Saudi patients
    Abd El-Kader, Shehab M.
    Al-Jiffri, Osama H.
    [J]. AFRICAN HEALTH SCIENCES, 2018, 18 (02) : 417 - 427
  • [2] Middle East Respiratory Syndrome
    Arabi, Yaseen M.
    Balkhy, Hanan H.
    Hayden, Frederick G.
    Bouchama, Abderrezak
    Luke, Thomas
    Baillie, J. Kenneth
    Al-Omari, Awad
    Hajeer, Ali H.
    Senga, Mikiko
    Denison, Mark R.
    Nguyen-Van-Tam, Jonathan S.
    Shindo, Nahoko
    Bermingham, Alison
    Chappell, James D.
    Van Kerkhove, Maria D.
    Fowler, Robert A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (06) : 584 - 594
  • [3] Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)
    Chan, JWM
    Ng, CK
    Chan, YH
    Mok, TYW
    Lee, S
    Chu, SYY
    Law, WL
    Lee, MP
    Li, PCK
    [J]. THORAX, 2003, 58 (08) : 686 - 689
  • [4] China National Health Commission, 2020, NEW COR PNEUM DIAGN
  • [5] The Effects of Viral Infection on Lymphocyte Metabolism: A New Perspective on Disease Characterization
    Dymond, Thomas
    [J]. VIRAL IMMUNOLOGY, 2018, 31 (04) : 278 - 281
  • [6] FEHR AR, 2015, METHOD MOL BIOL, V1282, DOI DOI 10.1007/978-1-4939-2438-7_1
  • [7] The Duffy null genotype is associated with a lower level of CCL2, leukocytes and neutrophil count but not with the clinical outcome of HTLV-1 infection
    Fernandes da Silva-Malta, Maria Clara
    Sales, Camila Campos
    Guimaraes, Jacqueline Cronemberger
    Goncalves, Poliane de Cassia
    Chaves, Daniel Goncalves
    Santos, Hadassa Campos
    Pereira, Alexandre da Costa
    Ribas, Joao Gabriel
    de Freitas Carneiro-Proietti, Anna Barbara
    Martins, Marina Lobato
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2017, 66 (08) : 1207 - 1216
  • [8] A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China
    Gong, Jiao
    Ou, Jingyi
    Qiu, Xueping
    Jie, Yusheng
    Chen, Yaqiong
    Yuan, Lianxiong
    Cao, Jing
    Tan, Mingkai
    Xu, Wenxiong
    Zheng, Fang
    Shi, Yaling
    Hu, Bo
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (15) : 833 - 840
  • [9] Clinical Characteristics of Coronavirus Disease 2019 in China
    Guan, W.
    Ni, Z.
    Hu, Yu
    Liang, W.
    Ou, C.
    He, J.
    Liu, L.
    Shan, H.
    Lei, C.
    Hui, D. S. C.
    Du, B.
    Li, L.
    Zeng, G.
    Yuen, K. -Y.
    Chen, R.
    Tang, C.
    Wang, T.
    Chen, P.
    Xiang, J.
    Li, S.
    Wang, Jin-lin
    Liang, Z.
    Peng, Y.
    Wei, L.
    Liu, Y.
    Hu, Ya-hua
    Peng, P.
    Wang, Jian-ming
    Liu, J.
    Chen, Z.
    Li, G.
    Zheng, Z.
    Qiu, S.
    Luo, J.
    Ye, C.
    Zhu, S.
    Zhong, N.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (18) : 1708 - 1720
  • [10] Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence
    Havrilesky, Laura J.
    Whitehead, Clark M.
    Rubatt, Jennifer M.
    Cheek, Robert L.
    Groelke, John
    He, Qin
    Malinowski, Douglas P.
    Fischer, Timothy J.
    Berchuck, Andrew
    [J]. GYNECOLOGIC ONCOLOGY, 2008, 110 (03) : 374 - 382